scispace - formally typeset
M

Mafalda Barbosa

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  30
Citations -  3915

Mafalda Barbosa is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Autism & Copy-number variation. The author has an hindex of 15, co-authored 28 publications receiving 2550 citations. Previous affiliations of Mafalda Barbosa include Instituto Gulbenkian de Ciência & Instituto Nacional de Saúde Dr. Ricardo Jorge.

Papers
More filters
Journal ArticleDOI

Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism

F. Kyle Satterstrom, +201 more
- 06 Feb 2020 - 
TL;DR: The largest exome sequencing study of autism spectrum disorder (ASD) to date, using an enhanced analytical framework to integrate de novo and case-control rare variation, identifies 102 risk genes at a false discovery rate of 0.1 or less, consistent with multiple paths to an excitatory-inhibitory imbalance underlying ASD.
Journal ArticleDOI

Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders

Dalila Pinto, +131 more
TL;DR: For example, the authors analyzed 2,446 ASD-affected families and confirmed an excess of genic deletions and duplications in affected versus control groups (1.41-fold, p = 1.0 × 10(-5)) and an increase in affected subjects carrying exonic pathogenic CNVs overlapping known loci associated with dominant or X-linked ASD and intellectual disability.
Journal ArticleDOI

Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism

F. Kyle Satterstrom, +153 more
TL;DR: Using an enhanced Bayesian framework to integrate de novo and case-control rare variation, 102 risk genes are identified at a false discovery rate of ≤ 0.1, consistent with multiple paths to an excitatory/inhibitory imbalance underlying ASD.
Journal ArticleDOI

Coffin–Siris Syndrome and the BAF Complex: Genotype–Phenotype Study in 63 Patients

Gijs W. E. Santen, +80 more
- 01 Nov 2013 - 
TL;DR: The emerging phenotype–genotype correlation is that SMARCB1 patients have the most marked physical phenotype and severe cognitive and growth delay, and the variability in phenotype seems most marked in ARIDs1A and ARID1B patients.